Conversion of Non-allosteric Pyruvate Kinase Isozyme into an Allosteric Enzyme by a Single Amino Acid Substitution*

(Received for publication, October 29, 1996, and in revised form, May 30, 1997)

Yoshitaka Ikeda , Takehiko Tanaka Dagger and Tamio Noguchi §

From the Department of Biochemistry, Fukui Medical School, 23-3 Shimoaizuki, Matsuoka, Fukui 910-02, Japan and the Dagger  Department of Nutrition and Physiological Chemistry, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Pyruvate kinase M1, a non-allosteric isozyme, was converted into an allosteric enzyme by replacement of an amino acid in the intersubunit contact. The substitution of Ala-398 with Arg resulted in the pronounced allosteric enzyme. The Hill coefficient and the substrate concentration giving one-half of Vmax for the mutant with respect to phosphoenolpyruvate were 2.7 and 0.41 mM, respectively, whereas those values for the wild type were 1.0 and 0.049 mM. This mutation, however, gave rise to only minor effects on the apparent values of Km for ADP and on Vmax. Furthermore, in contrast to the wild-type enzyme, the mutant was activated by fructose 1,6-bisphosphate. The Hill coefficient of the mutant was no longer increased by the allosteric inhibitor, L-phenylalanine, indicating that the equilibrium for the unligated enzyme is largely shifted toward the T-state. These results suggest that Ala-398 is one of the most critical residues allowing the enzyme to prefer the R-state and that allosteric regulation of pyruvate kinase involves amino acid residues in the intersubunit contact.


INTRODUCTION

Pyruvate kinase (PK,1 ATP:pyruvate 2-O-phosphotransferase, EC 2.7.1.40) catalyzes the transfer of a phosphoryl group of phosphoenolpyruvate (PEP) to ADP and plays a key role as a regulatory enzyme in the glycolytic pathway (1-3). In general, the enzyme displays homotropic cooperativity with respect to PEP. In mammalian allosteric PKs, fructose 1,6-bisphosphate (FBP), an intermediate metabolite of glycolysis, functions as an allosteric effector to activate the enzyme heterotropically (1, 4, 5). Four distinct isozymes, L, R, M1, and M2, occur in mammalian tissues and differ in regulatory properties. All these isozymes are known to be tetramers and are allosteric enzymes with the exception of M1 (1, 5-8).

The M1 and M2 isozymes are produced from a single gene locus by mutually exclusive alternative splicing (8-10); the M2 isozyme is expressed predominantly in the kidney, and M1 is predominant in skeletal muscle, heart, and brain (1). In addition, it is also known that expression of these isozymes shifts from M2 to M1 during development of some fetal tissues (2). In contrast to the other PK isozymes, M1 isozyme usually exhibits neither homotropic nor heterotropic allosteric effects (1, 5, 6). This isozyme, however, displays cooperative behavior under certain experimental conditions such as the presence of L-phenylalanine, an allosteric inhibitor (11-13). Furthermore, heterotropic activation of the M1 isozyme by FBP is observed only as a reversal of such an inhibited enzyme (14). Nevertheless, the biological significance of the lack of allosteric effects on the M1 isozyme is not fully understood.

In the rat PK-M1 and -M2 isozymes, the exon that is exchanged due to the alternative splicing encodes 56 amino acids, in which a total of 21 amino acid residues differ within a length of 35 residues (8, 9). Thus, it was proposed that the distinguishable kinetic properties of M1 and M2 isozymes could be attributed to these amino acid substitutions. Moreover, it has been shown by x-ray crystallographic analyses and computer modeling that the corresponding regions of their polypeptides participate directly in the intersubunit contact, which may be primarily responsible for the intersubunit communication required for allosteric cooperativity (15, 16). Therefore, it has been proposed that the amino acid residue(s) in the intersubunit contact of the allosteric isozymes, particularly in the two alpha  helices (Fig. 1, Calpha 1 and Calpha 2), play a central role in the allosteric interaction of the subunits (17, 18).


Fig. 1. The subunit structure of PK-M1. The subunit structure is drawn using coordinate data of the rabbit PK-M1 isozyme (36) with the computer program, RasMol. The highlighted region corresponds to the structural differences between the rat PK-M1 and -M2 isozymes. Two helices involved in the intersubunit contact (Calpha 1 and Calpha 2) are also indicated by arrows. Co-crystallized pyruvate is shown in the active site.
[View Larger Version of this Image (70K GIF file)]

The M1 isozymes of vertebrates seem to result from amino acid substitutions in ancestral allosteric isozymes since non-allosteric PKs such as the M1 isozyme have been found in vertebrates but never in microorganisms (19-22). The M1 isozyme is thought to be a specialized isozyme that arose in vertebrates for energy metabolism in particular tissues such as muscle and brain. The structure of the intersubunit contact of the PK-M1 isozyme appears to prefer the active conformation, as the isozyme has been regarded as a model of the R-state (14). Many studies have focused on the structures prerequisite to allosteric properties in PKs (17, 18, 23), while the structural basis of the maintenance of the R-state in the M1 isozyme still remains to be elucidated.

Since the primary structures of the M1 and M2 isozymes are identical except the region forming the intersubunit contact, the structure of the corresponding region of the M2 isozyme permits allosteric interactions whereas that of the M1 isozyme appears to prevent the enzyme from changing from its active conformation. To identify an amino acid residue required to maintain the active conformation as the R-state in the PK-M1 isozyme, our approach was to substitute the amino acid residues specific to the allosteric isozymes of PK so that we would convert the rat M1 isozyme into an allosteric enzyme. In the current study, we prepared a series of PK-M1 mutants in which the residues in the intersubunit contact were replaced and characterized them to examine whether the substitutions induce allosteric properties. This functional analysis provides insight into the contribution of a single amino acid residue to the maintenance of the R-state. In addition, since PK-M1 is the most stable isozyme in mammalian PKs, this allosteric mutant of PK-M1 might be available as a T-state model for further structural analyses such as x-ray crystallography.


EXPERIMENTAL PROCEDURES

Materials

Restriction endonuclease and DNA-modifying enzymes were purchased from Takara. Fructose 1,6-bisphosphate trisodium salt was from Sigma. Phosphoenolpyruvate and ADP were obtained from Wako Pure Chemicals and Oriental Yeast, respectively. Lactate dehydrogenase and NADH were products of Boehringer Mannheim. Oligonucleotide primers were synthesized by Greiner Japan. Other common chemicals were from Wako Pure Chemicals or Nacalai Tesque.

Construction of the Transfer Plasmid

A 5' SalI-PstI 0.65-kb fragment of rat PK-M1 cDNA, which we cloned previously (8), was subcloned into a pSVK3 vector (Pharmacia Biotech Inc.). Subsequently, a BamHI-PstI 0.67-kb fragment was excised from the resulting plasmid and then ligated into a pBluescript SK+. A 3' BglII-EcoRI 1.3-kb cDNA fragment was ligated downstream of the 5' cDNA fragment contained in that plasmid, following digestion by these restriction endonucleases. The BamHI-EcoRI 1.9-kb fragment, which contains the entire coding sequence, was excised from the resultant plasmid and inserted into a transfer vector, pVL1393 (Invitrogen).

Site-directed Mutagenesis

Site-directed mutagenesis was carried out according to Kunkel (24), as described previously (25). Prior to mutagenesis, the SphI-KpnI 0.2-kb fragment of rat PK-M1 cDNA, which contains the amino acid sequences different between the M1 and M2 isozymes, was subcloned into a pTV119N vector (Takara). Subsequently, a HindIII-KpnI fragment excised from the resultant plasmid was then ligated to pBluescript SK+. The uracil-substituted single-stranded template was prepared from Escherichia coli CJ236 transformed by the plasmid. The uracil-template was used with synthetic oligonucleotide primers to replace residues of the M1 isozyme with those of mammalian allosteric PKs. The oligonucleotide primers used in this study are follows: 5'-GCAGCCGTGTACCACCGCCTG-3' for replacement of Phe-389 by Tyr (designated as F389Y), 5'-GAAGAGCTTCGCCGAGCCTCC-3' for Ala-398 by Arg (A398R), 5'-GAGCTTGCGCGAGCGGCCCCCCAATCCACAGACCCC-3' for a double mutation of Ser-401 by Ala and Ser-402 by Pro (S401A/S402P), 5'-TCCACAGATCCCACCGAGGCCATG-3' for Leu-408 by Thr (L408T), 5'-TATAAATGTTGCGCAGCAGC-3' for Leu-423 by Cys (L423C), and 5'-GCAGCAGCCATCATAGTTCTG-3' for Leu-427 by Ile (L427I). The resulting mutations were verified by dideoxy sequencing using a DNA sequencer (Applied Biosystems, model 373A), as were the entire sequences subjected to mutagenesis. The corresponding region of the wild-type PK-M1 cDNA was replaced by each mutant sequence. The transfer plasmids for the mutant enzymes were constructed similarly to those of the wild-type enzyme and used for transfection.

Cell Culture and General Manipulation of Viruses

Spodoptera frugiperda (Sf) 21 cells were maintained at 27 °C in Grace's insect media (Life Technologies, Inc.) supplemented with 10% fetal bovine serum, 3.33 g/liter yeastolate, 3.33 g/liter lactalbumin hydrolysate, and 100 mg/liter kanamycin. Recombinant viruses were manipulated as described (26).

Preparation of Recombinant Viruses

The purified transfer plasmids containing the wild-type or mutant PK-M1 cDNA (1 µg) were co-transfected into 5 × 105 Sf21 cells with 10 ng of BaculoGold DNA (PharMingen), which was used as Autographa californica nuclear polyhedrosis viral genome. Transfection experiments were carried out by the Lipofectin (Life Technologies, Inc.) method (27), as described previously (28, 29). Media containing the recombinant viruses generated by homologous recombinations were collected 6 days after transfection. The recombinant viruses were further amplified to more than 5 × 107 plaque-forming units/ml prior to use.

Expression of Recombinant Rat PK-M1 in Insect Cells

2 × 108 Sf21 cells were infected with the recombinant viruses carrying either wild-type or mutant PK-M1 at multiplicity of infection of more than 8. The infected cells were harvested about 90 h postinfection to purify the expressed proteins.

Purification of the Recombinant Enzymes

Expressed recombinant PKs were purified basically according to Imamura and Tanaka (1). Sf21 cells producing the recombinant enzymes were pelleted by centrifugation at 2,500 × g for 10 min. The cells were homogenized in 20 mM Tris-HCl, 5 mM MgSO4, 1 mM EDTA, and 10 mM 2-mercaptoethanol (pH 7.5) with a Dounce homogenizer and were centrifuged at 10,000 × g to obtain clarified extracts. Subsequently, the supernatants were treated with polyethyleneimine to remove contaminated nucleic acids and then subjected to fractionation by 45-80% saturation of ammonium sulfate. After dialysis against 10 mM sodium phosphate, 2 mM MgSO4, and 10 mM 2-mercaptoethanol (pH 6.0), the enzymes were subjected to a phosphocellulose column (Whatman P-11) pre-equilibrated with the same buffer used in dialysis. After washing intensively with the buffer containing 80 mM KCl, the bound enzymes were eluted with an addition of 0.5 mM PEP to the wash buffer.

Electrophoresis

The purified enzymes were subjected to SDS-PAGE analysis on 10% gels, according to Laemmli (30). The proteins were visualized by Coomassie Brilliant Blue R-250.

Enzyme Activity Assay

Standard assay for PK activity was performed at 37 °C using 2 mM both PEP and ADP in 50 mM Tris-HCl buffer, 0.1 M KCl, 5 mM MgSO4, and 0.5 mM FBP (pH 7.5) as described (1). This substrate mixture (1 ml) also contained 17 units of lactate dehydrogenase and 0.17 mM NADH to monitor release of pyruvate as a change of absorbance at 340 nm. One unit of activity was defined as the quantity of the enzyme that released 1 µmol of pyruvate per min.

Kinetic Analyses

Enzymatic activity was assayed at 37 °C using various concentrations of PEP or ADP. The condition used for kinetics was the same as above except the substrates and effector. In assessment of parameters for one substrate, the concentration of the other was fixed at 2 mM. Ten different concentrations of PEP between 10 µM and 2.0 mM were used to obtain kinetic parameters for the substrate. When parameters for ADP were determined, six concentrations of the substrate from 62.5 µM to 2.0 mM were employed with the constant concentration of MgSO4 (5 mM). Therefore, the parameters obtained for ADP are apparent ones. Release of pyruvate was monitored using a Beckman DU-640 spectrophotometer by coupling with the lactate dehydrogenase-NADH system. Kinetic parameters were obtained by fitting data for varied concentrations of PEP to the Hill equation. The Michaelis-Menten equation was used to determine parameters for ADP. These calculations were carried out using non-linear regression analysis based on the Marquardt algorithm. When effects of FBP and L-phenylalanine on kinetic parameters were investigated, kinetic experiments were performed similarly in the presence of these allosteric effectors. In some kinetic analyses, the concentration ranges of PEP were varied around the S0.5 (the substrate concentration giving one-half of Vmax), depending on the properties of enzymes.

Protein Determination

Protein contents were determined according to the method of Bradford (31) using bovine serum albumin as a standard.


RESULTS

We used the baculovirus-insect cell system, which is known as one of the most powerful expression systems (32), to produce a sufficient amount of active recombinant rat PK-M1. When insect cells were infected with the recombinant virus carrying the PK-M1 cDNA, the PK activity increased to about 100 units/mg of cell protein 90 h after infection. The activity was more than 100 times greater than that in uninfected cells. As shown in Fig. 2, the expression level of the PK-M1 protein was apparently as high as 20% of the total soluble proteins in the infected cells. Thus, a large amount of the active enzyme of rat PK-M1 can be produced by the baculovirus system.


Fig. 2. Expression of rat PK-M1 isozyme in insect cells. Six µg of cell extracts from non-infected (lane 1) and recombinant virus-infected insect cells (lane 2) were analyzed on SDS-PAGE together with the purified recombinant rat PK-M1 isozyme (1 µg, lane 3). The left lane is a molecular mass marker.
[View Larger Version of this Image (80K GIF file)]

We obtained more than 10 mg of the purified enzyme from 2 × 108 cells infected with the recombinant virus. SDS-PAGE analysis demonstrates a single band of about 57 kDa, which corresponds to a single subunit of the M1 isozyme (Fig. 2). When the purified enzyme was subjected to a gel permeation chromatography on a fast protein liquid chromatography system equipped with Superose 12 (Pharmacia), the elution time of the recombinant enzyme was identical to that of the authentic M1 isozyme purified from rat muscle (data not shown), suggesting that the recombinant enzyme is a tetramer similar to the authentic isozyme (1, 2). In addition, kinetic properties of the recombinant M1 given in Table I were indistinguishable from those of the authentic rat M1 reported (1).

Table I. Kinetic parameters of the wild-type and mutant pyruvate kinases

Errors for parameters are expressed as S.D.

Enzyme Phosphoenolpyruvatea
ADPb
FBP(-)
FBP(+)c
Vmax(app) Km(app)
Vmax(app) S0.5d Hill coefficient Vmax(app) S0.5d Hill coefficient

µmol/min/mg mM µmol/min/mg mM µmol/min/mg mM
Wild type 480  ± 22 0.049  ± 0.010 1.0  ± 0.15 450  ± 17 0.045  ± 0.006 1.0  ± 0.10 540  ± 13 0.37  ± 0.024
F389Y 470  ± 10 0.11  ± 0.006 2.1  ± 0.19 490  ± 7 0.061  ± 0.003 1.6  ± 0.09 560  ± 21 0.36  ± 0.039
A398R 380  ± 4 0.41  ± 0.007 2.7  ± 0.10 380  ± 7 0.23  ± 0.010 2.2  ± 0.18 440  ± 18 0.35  ± 0.042
S401A/S402P 470  ± 9 0.13  ± 0.007 1.7  ± 0.12 450  ± 15 0.054  ± 0.006 1.4  ± 0.18 540  ± 4 0.31  ± 0.066
L408T 540  ± 11 0.089  ± 0.006 1.5  ± 0.13 500  ± 21 0.038  ± 0.006 1.4  ± 0.26 610  ± 20 0.29  ± 0.029
L423C 490  ± 26 0.17  ± 0.022 2.1  ± 0.48 510  ± 6 0.10  ± 0.003 1.6  ± 0.07 590  ± 21 0.34  ± 0.035
L427I 500  ± 10 0.068  ± 0.004 1.4  ± 0.01 490  ± 14 0.049  ± 0.005 1.2  ± 0.14 600  ± 22 0.39  ± 0.042

a Assayed in the presence of 2 mM ADP and 5 mM MgSO4.
b Determined with variable ADP in the presence of 2 mM PEP and 5 mM MgSO4.
c Activated with 1 mM FBP.
d Equivalent to Km for the wild type.

Amino acid sequences of the regions forming the intersubunit contacts of various PKs (7-10, 15, 37) were aligned to find candidate amino acid residues to be replaced for the conversion of PK-M1 into an allosteric enzyme (Fig. 3). Mutagenesis was used to introduce changes into the corresponding positions where residues are conserved in allosteric PKs but not in M1 isozymes. The residues indicated by arrowheads in rat PK-M1 were substituted by the corresponding amino acids that are conserved in allosteric PKs. The mutant M1 isozymes were expressed in insect cells and were purified as described under "Experimental Procedures." These purified mutants also exhibited a single protein band with apparent molecular mass of 57 kDa on SDS-PAGE (Fig. 4).


Fig. 3. Sequence alignment of amino acid residues in the intersubunit contacts of PKs from various vertebrates. Shaded boxes indicate residues identical to rat M2 isozyme. The regions corresponding to Calpha 1 and Calpha 2 are boxed. Arrowheads show the candidate residues to be examined in rat PK-M1. These are located at the positions where residues are conserved among allosteric PKs but not in M1 isozymes.
[View Larger Version of this Image (20K GIF file)]


Fig. 4. SDS-PAGE analysis of purified PK-M1 mutants and wild type. One µg of the purified enzymes were subjected to SDS-PAGE. The gel includes a molecular mass marker in the left lane.
[View Larger Version of this Image (92K GIF file)]

Kinetic behavior of the purified mutant M1 enzymes with respect to PEP are shown in Fig. 5, and Table I compares kinetic parameters of the mutants with those of the wild type. Consistent with earlier work (1, 6), the wild-type M1 demonstrated a hyperbolic response to the increasing concentrations of the substrate and essentially no activation by FBP. On the other hand, all of the substituted PK-M1 mutants exhibited a sigmoidal response to PEP to some extent and had greater S0.5 values. The S0.5 is analogous to the Km in non-allosteric enzymes such as the wild-type M1. Furthermore, the S0.5 values were sensitive to FBP, as their Hill coefficients and S0.5 values were decreased in the presence of 1 mM effector. Thus, every substitution resulted in appearance of both homotropic and heterotropic allosteric effects. The A398R mutant had the most pronounced homotropic cooperativity among the mutants, as indicated by its Hill coefficient of 2.7. This value was larger than the coefficient of 1.4-1.8 for the rat M2 isozyme (1, 14, 38). The S0.5 value of 0.41 mM for the A398R mutant was 8.4 times greater than that of the wild-type M1 (Table I) and was comparable to the value of 0.26-0.4 mM reported for the rat allosteric M2 isozyme (1, 38). Thus, a single substitution by arginine at position 398 is sufficient to convert the non-allosteric PK-M1 into a typical allosteric enzyme comparable to the PK-L, -R, and -M2 isozymes.


Fig. 5. Kinetic behaviors of the wild-type and mutants of rat PK-M1 isozyme with respect to PEP. Assays were carried out with various concentrations of PEP and 2 mM ADP in the absence (closed circles) and presence of 1 mM FBP (open circles). The condition used is described in detail under "Experimental Procedures." Velocities are expressed as the values normalized by Vmax. Curves are drawn by fitting data sets to the Hill equation with non-linear regression.
[View Larger Version of this Image (22K GIF file)]

To examine whether amino acid replacements caused concomitant effects on other kinetic parameters, apparent parameters of Vmax and Km for ADP were assessed by varying the concentrations of ADP in the presence of the fixed concentrations of PEP (2 mM) and MgSO4 (5 mM). Hyperbolic responses were observed in all of the mutants, similar to the wild-type PK-M1 (data not shown). Furthermore, none of the amino acid substitutions including the A398R caused any substantial changes of the apparent parameters for ADP (Table I). These results indicate that the substitutions affect the binding of PEP without any effect on the binding of ADP or on the catalysis.

Effects of FBP and L-phenylalanine on the A398R mutant were evaluated to characterize the nature of the allosteric properties of this mutant. It is known that these effectors act on the activity of PK through the shift of equilibrium of the allosteric transition between the active R-state and the inactive T-state (13, 14, 33). While FBP had little effect on the properties of the wild type (Fig. 6), the profile of the kinetic behavior of A398R changed remarkably from a sigmoidal curve to a nearly hyperbolic one as the concentration of FBP increased (Fig. 6B). As shown in Fig. 6, C and D, the S0.5 and Hill coefficient for A398R decreased in a simple saturating manner with the increase of FBP concentration. FBP caused little change in Vmax of the mutant. The FBP activation profiles observed for A398R seem to be similar to those reported by Consler et al. (14), in which rabbit muscle PK was activated by FBP in the presence of L-phenylalanine. Activation of the A398R mutant by FBP allowed this enzyme to behave similar to the wild type, indicating that the effects of the substitution of Ala-398 by Arg on the kinetic properties are reversal by FBP. These results suggest that the consequence of the substitution is a reversible change that shifts the allosteric transition from the R-state to the T-state.


Fig. 6. Activation of A398R mutant by FBP. A and B, effects of FBP on the responses of the wild type (A) and A398R mutant (B) to various concentrations of PEP. Enzyme activities were measured in the absence (bullet ) or presence of 0.5 mM (open circle ), 1.0 mM (black-triangle), 2.0 mM (triangle ), 4.0 mM (black-diamond ), and 8.0 mM (diamond ) FBP. Velocities are normalized by Vmax values calculated from the data set at each FBP concentration. C and D, effects of the activator on S0.5 values (C) and Hill coefficients (D) of the wild type (open circle ) and the mutant (bullet ).
[View Larger Version of this Image (25K GIF file)]

The other allosteric effector, L-phenylalanine, exhibits inhibitory effects by shifting the allosteric transition toward the T-state (14). S0.5 values increase with L-phenylalanine concentration, revealing that the T-state became predominant relative to the R-state in both the wild type and A398R mutant (Fig. 7, A, B, and C). In the wild type, the Hill coefficient increased from 1.0 up to about 2.5 in the range of the L-phenylalanine concentrations examined (Fig. 7, A and D). In contrast, the Hill coefficient of the mutant was not increased further by L-phenylalanine, but rather decreased at higher concentrations of the effector (Fig. 7D). Thus, these results show that the homotropic cooperativity of this mutant for PEP is nearly at its maximum and that the state of the allosteric transition in the unligated enzyme is largely shifted toward the T-state.


Fig. 7. Effects of an allosteric inhibitor on the kinetic properties of the wild-type and A398R mutant PK isozymes. A and B, the inhibitory effects of L-phenylalanine on enzyme activities of the wild type (A) and A398R mutant (B). L-Phenylalanine concentrations used for the wild type: 0 mM (bullet ), 0.5 mM (open circle ), 1.0 mM (black-triangle), 2.0 mM (triangle ), and 4.0 mM (black-diamond ) and for the mutant: 0 mM (bullet ), 0.05 mM (open circle ), 0.1 mM (black-triangle), 0.2 mM (triangle ), 0.4 mM (black-diamond ), 0.8 mM (diamond ), and 1.6 mM (black-down-triangle ). Velocities were normalized as described in Fig. 6. C, the S0.5 values of the wild type (bullet ) and the mutant (open circle ) are plotted as a function of L-Phe concentration. D, distinct effects of the inhibitor on the Hill coefficients of the wild type (bullet ) and the mutant (open circle ) are shown.
[View Larger Version of this Image (27K GIF file)]


DISCUSSION

In the present study, we examined the effects of amino acid substitutions on the kinetic properties of the rat PK-M1 isozyme to identify the residues responsible for the enzyme to favor the R-state. Our results suggest that Ala-398 is a critical residue for the stabilization of the R-state in the PK-M1 isozyme. The requirement of Ala-398 for maintenance of the R-state was revealed by a major disturbance of the allosteric properties of the A398R mutant (Fig. 5). The other residues examined in this study appear to participate, at least in part, in exhibition of the unique kinetic properties of the PK-M1 isozyme distinct from allosteric isozymes since replacements of these residues also affected the properties of the PK-M1 isozyme, albeit to a lesser extent. It seems that the subtle interactions of residues in the intersubunit contact allow the PK-M1 isozyme to barely maintain its active conformation regarded as the R-state.

Although Ala-398 has been shown to play an important role for the rat PK-M1 isozyme to exhibit non-allosteric properties, the alanine residue is not conserved among M1 isozymes from other species. Amino acids with aliphatic side chains of various lengths are common to position 398 or its equivalent position for all of the M1 isozymes (Fig. 3). Therefore, it seems likely that allosteric effects are induced in the rat PK-M1 by introduction of a positive charge to position 398 rather than by that of a bulky side chain. Furthermore, Ala-398 is located at a position that is able to interact with Arg-391 of the symmetrically associated subunit (16), a residue that is also conserved in L and R isozymes but not in M2 isozyme. This could account for a more pronounced cooperativity found in the A398R mutant than for the native M2 isozyme. It is possible that an interaction of the arginine residue introduced into position 398 with Arg-391 of the facing subunit could contribute significantly to the occurrence of more cooperative behavior.

The reaction mechanism of PK is believed to involve the ternary complex that consists of PEP, ADP, and the enzyme (15). In this view, the transfer of a phosphoryl group occurs directly from PEP to ADP, and does not proceed via a phosphoenzyme species. The subsites for binding of these substrates must be very close to each other to carry out the direct transfer. Nonetheless, operations of the residues in the intersubunit contact induced both homotropic and heterotropic allosteric effects in the PK-M1 isozyme without substantial changes of the apparent Km for ADP and of the catalytic constant, indicating that the effects of the amino acid replacements are specific to the binding of PEP and do not affect arrangement of catalytic residues or the subsite for ADP binding. Therefore, it is unlikely that gross structural effects occurred in the mutants resulting in a distortion of the PEP-binding site. The mutants of the PK-M1 isozymes seem to mimic the allosteric transition displayed by the native allosteric isozymes. These are consistent with the suggestion that the amino acid residues in the intersubunit contact region regulate the state of the allosteric transition of PKs.

In the FBP activation profile of A398R, data fitting by a simple saturation model reveals that the apparent activation constant for FBP is about 1 mM (Fig. 6, C and D). This value is much higher than micromolar or submicromolar levels for native allosteric PKs such as M2 and L isozymes (1). In contrast to these allosteric isozymes, the low binding affinity for FBP is intrinsic to mammalian M1 isozymes, as indicated by the apparent activation constant of millimolar range (14). Therefore, the amino acid substitution has no significant effect on the binding of FBP since it is likely that the replacement leads to no alteration in the intrinsic properties of the M1 isozyme. This suggests that the mutation introduced into the intersubunit contact does not change the local environment at the FBP-binding site.

Vertebrate PK-M1 isozymes are predominantly expressed in muscle, heart, and brain, organs that are always more energy-consuming than other organs and tend to demand more glucose. Those organs seem to prefer smooth consistent catabolism of glucose rather than a demand-regulated metabolism. The reaction catalyzed by the PK-M1 isozymes might not be a rate-limiting step in the course of glycolysis because of lack of allosteric regulation. These circumstances could lead to the specialized uncontrollable properties of the vertebrate PK-M1 isozymes during evolution. In fact, a non-allosteric PK such as M1 isozyme has not been found in microorganisms including bacteria and yeast (19-22). Hence, the PK-M1 isozyme is likely to be a highly specialized descendant of allosteric PKs. This specialization for PK might have been accomplished as a result of a shift in the allosteric state by a relatively small number of amino acid substitutions.

In the current study, we showed that a single amino acid substitution in the intersubunit contact converts the non-allosteric PK-M1 isozyme into a more typical allosteric form of PK. For mammalian PKs, only the crystal structures of M1 isozymes have been solved as an R-state conformation. On the other hand, it would be difficult to prepare crystals of the T-state form available for structural analysis in mammalian allosteric PKs such as M2 and L isozymes probably because they are unstable without FBP. The stability of A398R, the most pronounced allosteric mutant, was found to be comparable to that of the wild-type PK-M1 isozyme, as it could be purified and stored in the absence of a stabilizing agent such as FBP. Hence, this mutant is available as a stable model of PK in the T-state and might enable us to prepare a crystal of the T-state of mammalian PKs.

Recently, the unligated PK of E. coli was crystallized as the T-state conformation, and its crystal structure has been solved. The comparison between the structures of the E. coli PK (as the T-state) and mammalian M1 isozyme (as the R-state) showed that rotatory movements of domains give rise to the allosteric transition (34-36). However, similar structural analysis with the mutant and the wild-type PK-M1 isozyme would allow a direct comparison of the R-state and the T-state in the identical enzyme with the exception of only a single residue and thereby might provide a more detailed molecular basis of the transition.


FOOTNOTES

*   This research was supported in part by Grants-in-Aid for Encouragement of Young Scientists and for Scientific Research (C) from the Ministry of Education, Science, Sports and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed. Tel.: 81-776-61-3111 (Ext. 2225); Fax: 81-776-61-8102.
1   The abbreviations used are: PK, pyruvate kinase; PEP, phosphoenolpyruvate; FBP, fructose 1,6-bisphosphate; S0.5, substrate concentration giving one-half of Vmax; PAGE, polyacrylamide gel electrophoresis; kb, kilobase(s); Vmax(app), apparent Vmax; Km(app), apparent Km.

ACKNOWLEDGEMENTS

We are grateful to Drs. Donald Scott and Kazuya Yamada for critical reading of the manuscript.


REFERENCES

  1. Imamura, K., and Tanaka, T. (1982) Methods Enzymol. 90, 150-165 [Medline] [Order article via Infotrieve]
  2. Imamura, K., Noguchi, T., and Tanaka, T. (1986) in Markers of Human Neuroectodermal Tumors (Staal, G. E., and van Veelen, C. W. M., eds), pp. 191-222, CRC Press, Boca Raton, FL
  3. Ibsen, K. H. (1977) Cancer Res. 37, 341-353 [Abstract]
  4. Kahn, A., and Marie, J. (1982) Methods Enzymol. 90, 131-140 [Medline] [Order article via Infotrieve]
  5. Gardenas, J. M. (1982) Methods Enzymol. 90, 140-149 [Medline] [Order article via Infotrieve]
  6. Gardenas, J. M., Dyson, R. D., and Strandholm, J. J. (1975) in Isozymes (Markert, C. L., ed), Vol. 1, pp. 523-541, Academic Press, New York
  7. Noguchi, T., Yamada, K., Inoue, H., Matsuda, T., and Tanaka, T. (1987) J. Biol. Chem. 262, 14366-14371 [Abstract/Free Full Text]
  8. Noguchi, T., Inoue, H., and Tanaka, T. (1986) J. Biol. Chem. 261, 13807-13812 [Abstract/Free Full Text]
  9. Takenaka, M., Noguchi, T., Inoue, H., Yamada, K., Matsuda, T., and Tanaka, T. (1989) J. Biol. Chem. 264, 2363-2367 [Abstract/Free Full Text]
  10. Takenaka, M., Noguchi, T., Sadahiro, S., Hirai, H., Yamada, K., Matsuda, T., Imai, E., and Tanaka, T. (1991) Eur. J. Biochem. 198, 101-106 [Abstract]
  11. Consler, T. G., Jennewein, M. J., Cai, G.-Z., and Lee, J. C. (1990) Biochemistry 29, 10765-10771 [Medline] [Order article via Infotrieve]
  12. Consler, T. G., Jennewein, M. J., Cai, G.-Z., and Lee, J. C. (1992) Biochemistry 31, 7870-7878 [Medline] [Order article via Infotrieve]
  13. Oberfelder, R. W., Lee, L. L.-Y., and Lee, J. C. (1984) Biochemistry 23, 3813-3821 [Medline] [Order article via Infotrieve]
  14. Consler, T. G., Woodard, S. H., and Lee, J. C. (1989) Biochemistry 28, 8756-8764 [Medline] [Order article via Infotrieve]
  15. Muirhead, H., Clayden, D. A., Barford, D., Lorimer, C. G., Fothergill-Gilmore, L. A., Schiltz, E., and Schmitt, W. (1986) EMBO J. 5, 475-481 [Abstract]
  16. Muirhead, H. (1990) Biochem. Soc. Trans. 18, 193-196 [Medline] [Order article via Infotrieve]
  17. McNally, T., and Fothergill-Gilmore, L. A. (1990) Biochem. Soc. Trans. 18, 258 [Medline] [Order article via Infotrieve]
  18. Collins, R. A., McNally, T., and Fothergill-Gilmore, L. A. (1992) Biochem. Soc. Trans. 21, 63S
  19. Crow, V. L., and Pritchard, G. G. (1982) Methods Enzymol. 90, 165-170 [Medline] [Order article via Infotrieve]
  20. Malcovati, M., and Valentini, G. (1982) Methods Enzymol. 90, 170-179 [Medline] [Order article via Infotrieve]
  21. Murcott, T. H. L., McNally, T., Allen, S. C., Fothergill-Gilmore, L. A., and Muirhead, H. (1991) Eur. J. Biochem. 198, 513-519 [Abstract]
  22. Walker, D., Chia, W. N., and Muirhead, H. (1992) J. Mol. Biol. 228, 265-276 [Medline] [Order article via Infotrieve]
  23. Collins, R. A., McNally, T., Fothergill-Gilmore, L. A., and Muirhead, H. (1995) Biochem. J. 310, 117-123 [Medline] [Order article via Infotrieve]
  24. Kunkel, T. A. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 488-492 [Abstract]
  25. Ikeda, Y., Fujii, J., Taniguchi, N., and Meister, A. (1995) J. Biol. Chem. 270, 12471-12475 [Abstract/Free Full Text]
  26. Piwnica-Worms, H. (1987) in Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., eds), pp. 16.8.1-16.11.7, Greene Publishing Associates and Wiley-Interscience, New York
  27. Felgner, P. L., Gadek, T. R., Holm, H., Roman, R., Chan, H. W., Wenz, M., Northrop, J. R., Ringold, G. M., and Danielsen, M. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7413-7417 [Abstract]
  28. Ikeda, Y., Fujii, J., Taniguchi, N., and Meister, A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 126-130 [Abstract]
  29. Ikeda, Y., Fujii, J., Anderson, M. E., Taniguchi, N., and Meister, A. (1995) J. Biol. Chem. 270, 22223-22228 [Abstract/Free Full Text]
  30. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  31. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  32. Luckow, V. A., and Summers, M. D. (1988) Bio/Technology 6, 47-55
  33. Kayne, F. J., and Price, N. C. (1972) Biochemistry 11, 4415-4420 [Medline] [Order article via Infotrieve]
  34. Mattevi, A., Bolognesi, M., and Valentini, G. (1996) FEBS Lett. 389, 15-19 [CrossRef][Medline] [Order article via Infotrieve]
  35. Mattevi, A., Valentini, G., Rizzi, M., Speranza, M. L., Bolognesi, M., and Coda, A. (1995) Structure 3, 729-741 [Abstract]
  36. Larsen, T. M., Laughlin, T., Holden, H. M., Rayment, I., and Reed, G. H. (1994) Biochemistry 33, 6301-6309 [Medline] [Order article via Infotrieve]
  37. Lonberg, N., and Gilbert, W. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 3661-3665 [Abstract]
  38. Schering, B., Eigenbrodt, E., Linder, D., and Schoner, W. (1982) Biochim. Biophys. Acta 717, 337-347 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.